BiotechTube
Home/Avidicure/Govert Schouten
GS

Govert Schouten

CBO

Avidicure

Therapeutic Areas

OncologyAutoimmune Diseases

Avidicure Pipeline

DrugIndicationPhase
AVC-S-201AML and other blood cancers/solid tumorsPreclinical

Leadership Team at Avidicure

AL
Arthur Lahr
CEO
DD
Dirk De Naeyer
COO
RF
Robert Friesen
CSO
View full Avidicure profile